Handelsavisen
prelaunch
Companies Healthcare 475960.KQ
47
475960.KQ KOSDAQ Advanced Medical Equipment & Technology

Tomocube Inc

$47 000,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
626,1B KRW
P/E
EV / Rev
Div yield
0,00 %
Op margin
-49,2 %
ROE
-12,4 %
Net margin
-42,5 %
Debt / equity
0,03
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Tomocube Inc is a South Korean company specializing in the development and production of advanced medical equipment and technology, primarily focused on diagnostic imaging systems and related healthcare solutions.

Business. Tomocube Inc (475960.KQ) is a healthcare company specializing in advanced medical equipment and technology. The firm operates within the Healthcare Services & Equipment industry, focusing on the development and sale of healthcare equipment. Tomocube is headquartered in South Korea and is primarily listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
1 analysts · indicative
Ownership
not yet wired
Profitability
-12,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 475960.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 475960.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Tomocube Inc (475960.KQ) is a healthcare company specializing in advanced medical equipment and technology. The firm operates within the Healthcare Services & Equipment industry, focusing on the development and sale of healthcare equipment. Tomocube is headquartered in South Korea and is primarily listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    Tomocube's capital structure is characterized by a high liquidity position, with cash and equivalents amounting to KRW 11,449,134,440, which is significantly higher than its total liabilities of KRW 2,717,675,800. The company's liquidity ratio of 23.15 indicates a strong ability to meet short-term obligations. However, the company's price-to-book ratio of 16.04 suggests that the market is valuing the company at a premium relative to its book value, which may reflect expectations of future growth or innovation.

    Profitability metrics for Tomocube are currently negative, with a net loss of KRW 4,810,012,370 and an operating loss of KRW 5,567,639,090. The return on equity (ROE) is -12.4%, and the return on assets (ROA) is -11.59%, both of which are significantly below the industry median for the Advanced Medical Equipment & Technology sector. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to market-specific risks, particularly in the South Korean healthcare equipment market.

    Looking ahead, Tomocube is expected to see a significant increase in revenue, with analysts forecasting a jump from KRW 11,306,726,320 to KRW 23,200,000,000 in the current fiscal year. However, the company's operating cash flow remains negative at KRW -6,754,417,130, and free cash flow is also negative at KRW -4,070,681,630, indicating that the company is not yet generating sufficient cash from operations to fund its activities.

    Risk factors for Tomocube include the potential for dilution, although the risk is currently assessed as low. The company has not issued additional shares recently, and there are no immediate filing-based liquidity or dilution flags. However, the company's high debt-to-equity ratio of 0.03 suggests that it is not heavily leveraged, which is a positive sign for financial stability.

    Recent events include the release of the latest financial statements, which show continued losses but also a strong cash position. There are no recent filings or transcripts indicating significant changes in the company's strategic direction or operational performance.

    Key takeaways
    • Tomocube has a strong liquidity position with a current ratio of 23.15, indicating a robust ability to meet short-term obligations.
    • The company is currently unprofitable, with a net loss of KRW 4,810,012,370 and a negative ROE of -12.4%.
    • Analysts expect a significant revenue increase in the current fiscal year, forecasting a jump to KRW 23,200,000,000.
    • The company's revenue is concentrated in a single business segment, increasing exposure to market-specific risks.
    • Tomocube's high price-to-book ratio of 16.04 suggests the market is valuing the company at a premium, potentially reflecting expectations of future growth.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $47 000,00
    Market cap
    $622.13B
    Enterprise value
    $611.76B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    16.0x
    P / Tangible book
    16.0x
    Tangible book
    $38.79B
    Net cash
    $10.37B
    Current ratio
    23.1
    Debt / equity
    0.0
    ROA
    -11.6%
    ROE
    -12.4%
    Cash conversion
    140.0%
    CapEx / revenue
    -6.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy1
    Buy0
    Hold0
    Sell0
    Strong sell0
    Operating income · consensus2,3B KRW

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-49,2 %Below median
    Net Margin-42,5 %Below median
    ROE-12,4 %Below median
    Capex / Rev-6,8 %Below median
    D/E0,03Above median
    Cash Conv1,40Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • Tomocube Inc Market data — financials · 2026-05-26
    • Tomocube Inc Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    475960.KQCanonical
    KOSDAQ · KRW

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage